NanoPhoria

AnaCardio

This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.

Brano Therapeutics

This company develops small-molecule inhibitors to treat heart failure and metabolic dysfunction for patients with cardiovascular diseases.

InCarda Therapeutics

This biopharmaceutical company develops inhaled therapies to treat patients with acute cardiovascular conditions such as paroxysmal atrial fibrillation.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.

Nanophagix

This biotechnology firm develops chemical conjugates and nanoparticle drug delivery platforms for pharmaceutical companies to treat atherosclerosis and other cardiovascular conditions.

HeartKinetics

This digital health company develops non-invasive remote monitoring devices and applications for patients and cardiologists to detect and manage heart failure symptoms.

preCARDIA

This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.